Nadh Plus label

Nadh Plus

Nadh Plus Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

WARNINGS:  If pregnant or breast-feeding, ask a health care professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing.  Store in a cool, dry place.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

INDICATIONS:  For temporary relief of mental fatigue, for improving concentration, for improving energy, and for chronic fatigue.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Nadh Plus Manufacturers

  • Nadh Plus | Apotheca Company
    No Recall

    Nadh Plus | Apotheca Company

    Nadh Plus | Apotheca Company

    DIRECTIONS:  Three sprays per day.  Hold in mouth for two minutes.  Consult a physician for use in children under 12 years of age.

  • Nadh Plus | Octapharma Usa Inc
    No Recall

    Nadh Plus | Octapharma Usa Inc

    Nadh Plus | Octapharma Usa Inc

    For intravenous use only

    Administer Octaplas based on AB0-blood group compatibility.

    2.1 Dose

    Replacement of coagulation factors in patients with acquired deficiencies due to liver disease or undergoing cardiac surgery or liver transplant

    Initially infuse of 10 to 15 mL Octaplas per kilogram body weight. This should increase the patient’s plasma coagulation factor levels by approximately 15-25%. If hemostasis is not achieved, use higher doses.

    Adjust dose based on desired clinical response.

    Monitor response, including measurement of activated partial thromboplastin time (aPTT), prothrombin time (PT), and/or specific coagulation factors.

    Plasma exchange in patients with TTP

    Completely replace plasma volume removed during plasmapheresis with Octaplas. Generally, 1 to 1.5 plasma volumes corresponds to 40 to 60 milliliters per kg. [ 1,2 ]

    2.2 Administration

    Administer Octaplas after thawing using an infusion set with a filter.

    Octaplas should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if turbid.

    Avoid shaking.

    Steps for Thawing:

    For water bath: Thaw in the outer wrapper for up to 30 minutes in a circulating water bath at +30°C to +37°C (86°F to 98.6°F).An overwrap bag may be used to provide further protection of contents if appropriate. Prevent water from contaminating the entry port. The minimum thawing time is 30 minutes at 37°C (98.6°F). The thawing time depends on the number of bags in the water bath. If more than one plasma bag is thawed in the same water bath, then the thawing time can be prolonged, but should not exceed 60 minutes. For dry tempering system: Place the Octaplas bags between the heating plates according to the manufacturer´s instructions. Thaw plasma following manufacturer directions between +30°C to +37°C (86°F to 98.6°F). Remove the product when the thawing process is completed. The thawing process may be monitored and recorded using the thawing device printer or barcode scanner recommended by the device manufacturer. Monitor the thawing process and record using the thawing device printer or barcode scanner recommended by the device manufacturer.

    Do not freeze Octaplas. Discard unused product.